In CLL cells, CD40 activation by microenvironmental CD40-ligand expressing cells (such as T-follicular cells or fibroblasts) upregulates Bcl-xL and Mcl-1, thus conferring resistance to Bcl-2 inhibition [77, 95, 96]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.